Theralizumab, CAS [[906068-56-2]]

Produktübersicht

• Artikelname: Theralizumab, CAS [[906068-56-2]]
• Artikelnummer: MCE-HY-P9975
• Hersteller Artikelnummer: HY-P9975
• Alternativnummer: MCE-HY-P9975-5MG,MCE-HY-P9975-10MG,MCE-HY-P9975-1MG,MCE-HY-P9975-25MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: TGN1412, TAB08

Produktbeschreibung

Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis[1][2].

Produkteigenschaften

• Molekulargewicht: (145.62 kDa)
• Reinheit: 99.46
• CAS Nummer: [906068-56-2]
• Target-Kategorie: CD28

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies